Please use this identifier to cite or link to this item:
https://hdl.handle.net/11147/14763
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Uzuner,E. | - |
dc.contributor.author | Kiraz,Y. | - |
dc.contributor.author | Baran,Y. | - |
dc.date.accessioned | 2024-09-24T15:54:15Z | - |
dc.date.available | 2024-09-24T15:54:15Z | - |
dc.date.issued | 2020 | - |
dc.identifier.isbn | 978-012819541-3 | - |
dc.identifier.uri | https://doi.org/10.1016/B978-0-12-819541-3.00023-2 | - |
dc.identifier.uri | https://hdl.handle.net/11147/14763 | - |
dc.description.abstract | Cancer cells divide continuously without any control, rendering immortal cells. These changes cause the dynamic instability in their genomes. Therefore each cancer cell in a tumor mass has various changes for specific tumor types. Their differences should be diagnosed on the basis of mutated genes and/or proteins. After the detection of alterations in cancer cells based on the techniques and instruments of biomedicine, personalized therapy continues with preexisting drug implementations. Personalized therapy broadens the borders with circulating tumor cells causing the metastasis in distant regions, developing specific gene therapies, novel targeted drugs, and immunotherapeutics for eliminating cancerous cells precisely. Within this context, biomedicine helps humankind to merge the biological and physiological knowledge to clinical practice. In this chapter, we aimed to clarify attitudes in biomedicine from molecular changes from single tumor cells to in vivo studies to find the best therapy for a cancer patient. © 2020 Elsevier Inc. All rights reserved. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.ispartof | Biodiversity and Biomedicine: Our Future | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | cancer-cell specific sequencing | en_US |
dc.subject | circulating tumor cells | en_US |
dc.subject | drug implementations | en_US |
dc.subject | gene therapies | en_US |
dc.subject | genetic profiling | en_US |
dc.subject | genetic tests | en_US |
dc.subject | immunotherapies | en_US |
dc.subject | marker-based drug therapies | en_US |
dc.subject | personalized therapies | en_US |
dc.subject | Tumor-specific changes | en_US |
dc.title | Tumor-specific genetic profiling and therapy in biomedicine | en_US |
dc.type | Book Part | en_US |
dc.department | Izmir Institute of Technology | en_US |
dc.identifier.startpage | 459 | en_US |
dc.identifier.endpage | 485 | en_US |
dc.identifier.scopus | 2-s2.0-85147599383 | - |
dc.relation.publicationcategory | Kitap Bölümü - Uluslararası | en_US |
dc.identifier.doi | 10.1016/B978-0-12-819541-3.00023-2 | - |
dc.authorscopusid | 57242876200 | - |
dc.authorscopusid | 56422406900 | - |
dc.authorscopusid | 9636164400 | - |
dc.identifier.wosquality | N/A | - |
dc.identifier.scopusquality | N/A | - |
item.fulltext | No Fulltext | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.openairetype | Book Part | - |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection |
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.